| 000 | 01424 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516082302.0 | ||
| 264 | 0 | _c20130301 | |
| 008 | 201303s 0 0 eng d | ||
| 022 | _a1740-2530 | ||
| 024 | 7 |
_a10.1155/2012/480429 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChandramohan, Vidyalakshmi | |
| 245 | 0 | 0 |
_aToxin-based targeted therapy for malignant brain tumors. _h[electronic resource] |
| 260 |
_bClinical & developmental immunology _c2012 |
||
| 300 |
_a480429 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Review | ||
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aBrain Neoplasms _ximmunology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aGlioma _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotoxins _xadministration & dosage |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 | _aPrecision Medicine |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProteomics |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTumor Microenvironment _ximmunology |
| 700 | 1 | _aSampson, John H | |
| 700 | 1 | _aPastan, Ira | |
| 700 | 1 | _aBigner, Darell D | |
| 773 | 0 |
_tClinical & developmental immunology _gvol. 2012 _gp. 480429 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2012/480429 _zAvailable from publisher's website |
| 999 |
_c21605615 _d21605615 |
||